An economic evaluation of sevelamer in patients new to dialysis

Author： Taylor Matthew J. Elgazzar Heba A. Chaplin Stephen Goldsmith David Molony Donald A.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.2, 2008-02, pp. : 601-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom

By Thompson Melissa

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 744-755

Informa Healthcare

Access to resources Recommend Favorite

Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysis

By Grima Daniel T. Dunn Elizabeth S. Bernard Lisa M. Mendelssohn David C.

Current Medical Research and Opinion, Vol. 29, Iss. 2, 2013-02 ,pp. : 109-115

Informa Healthcare

Access to resources Recommend Favorite

Sevelamer

Nephron Clin Pract, Vol. 94, Iss. 3, 2004-11 ,pp. : c53-c58

Karger

Access to resources Recommend Favorite

Glucose‐Lowering Effect of Sevelamer Hydrochloride in Hemodialysis Patients

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 4, 2015-08 ,pp. : 412-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation and Determinants of Underprescription of Erythropoiesis Stimulating Agents in Pre-Dialysis Patients with Anaemia

Nephron Clin Pract, Vol. 108, Iss. 1, 2008-01 ,pp. : c67-c74

Karger

Access to resources Recommend Favorite